Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Carlos Salinas, Alex Renner, Carlos Rojas, Suraj Samtani, Mauricio Burotto

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.

Original languageEnglish
Pages (from-to)621-626
Number of pages6
JournalCase Reports in Oncology
Volume13
Issue number2
DOIs
StatePublished - 2020

Bibliographical note

Publisher Copyright:
© 2020 S. Karger AG. All rights reserved.

Keywords

  • Immune-related adverse events
  • Ipilimumab
  • Nivolumab
  • Primary adrenal insufficiency

Fingerprint

Dive into the research topics of 'Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature'. Together they form a unique fingerprint.

Cite this